ReviewBladder (San Francisco, Calif.)2023

Advances in HER2-Targeted Treatment for Advanced/Metastatic Urothelial Carcinoma.

Mengnan Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.